Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: A retrospective Eurocord-EBMT analysis

Bone Marrow Transplantation

Volumn 49, Issue 1, 2014, Pages 24-29

  Cunha, R ^a   Loiseau, P ^a   Ruggeri, A ^a   Sanz, G ^b   Michel, G ^c   Paolaiori, A ^d   Socie G ^a   Arcese, W ^e   Picardi, A ^e   Dias De Heredia, C ^f   Rio, B ^g   Locatelli, F ^h   O'Brien, T A ⁱ   Yakoub Agha, I ^j   Angel Diaz, M ^k   Milpied, N ^l   Bittencourt, H ^m   Pedro Souza, M ⁿ   Aljurf, M ^o   Charron, D ^a   Boudjedir, K ^a   Labopin, M ^p   Gluckman, E ^a   Rocha, V ^a,q   more..

^a SAINT LOUIS HOSPITAL   (France)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c TIMONE HOSPITAL   (France)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HÔTEL DIEU   (France)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ SYDNEY CHILDREN'S HOSPITAL   (Australia)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^l BORDEAUX UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY OF MONTREAL   (Canada)

ⁿ Hospital Amaral Carvalho   (Brazil)

^o KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^p HÔPITAL SAINT ANTOINE   (France)

^q UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Cord blood transplantation; HLA mismatches direction; Malignant diseases

Indexed keywords

HLA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; DONOR; FEMALE; GENE LOCUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HLA MISMATCH DIRECTION; HOMOZYGOSITY; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HOMOZYGOTE; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891862507     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.120     Document Type: Article

References (25)

1. Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft-and transplantation-related factors. Br J Haematol 2009; 147: 262-274.
2. Petersdorf EW. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008; 20: 588-593.
3. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802.
4. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Eng J Med 2000; 342: 1846-1854.
5. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410-2415.
6. van Rood JJ, Stevens CE, Smits J, Carrier C, Carpenter C, Scaradavou A. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci USA 2009; 106: 19952-19957.
7. van den Boogaardt DE, van Rood JJ, Roelen DL, Claas FH. The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int 2006; 19: 360-371.
8. Koegler G, Enczmann J, Rocha V, Gluckman E, Wernet P. High-resolution HLA typing sequencing for HLA-A,-B,-C,-DR,-DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005; 36: 1033-1041.
9. Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009; 114: 1689-1695.
10. Stevens CE, Carrier C, Carpenter C, Sung D, Scaradavou A. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood 2011; 118: 3969-3978.
11. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLAidentical siblings. J Clin Oncol 1997; 15: 1767-1777.
12. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491-505.
13. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
15. Fine JP, Gray RJ. A proportional hazards model for the sub distribution of a competing risk. J Am Stat Assoc 1999; 94: 496-499.
16. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187.
17. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan K-W et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
18. Eapen M, Klein J, Sanz GF, Spellman S, Ruggeri A, Anasetti C et al. Effect of donorrecipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilicalcord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011; 12: 1214-1221.
19. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583.
20. Loiseau P, Busson M, Balere M-L, Dormoy A, Bignon J-D, Gagne K et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A,-B,-C,-DRB1 or-DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007; 13: 956-974.
21. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft versus host disease and implication for its molecular mechanism. Blood 2007; 110: 2235-2241.
22. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197-204.
23. Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H et al. The impact of anti-HLA antibodies on unrelated donor cord blood transplantations. Blood 2010; 116: 2839-2846.
24. Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S et al. The detection of donor-directed, HLA specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010; 115: 2704-2708.
25. Ciurea S, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009; 88: 1019-1024.